Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

Status:
Terminated

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the effects of AV608, a neurokinin 1 (NK-1) antagonist, in subjects with Idiopathic Detrusor Overactivity.

Phase 2

Avera Pharmaceuticals